BVS Stock Price - Bioventus Inc. logo

BVS Stock Price

Bioventus Inc.

$13.50
-$0.06(-0.44%)
66
Overall
80
Value
70
Tech
50
Quality
How is this score calculated?
Market Cap
$1.14B
Volume
338.40K
52W Range
$6.46 - $15.89
Target Price
$17.60

BVS stock price is $13.50 (-0.44% on the day), giving Bioventus Inc. a market cap of $1.14B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

BVS Stock Overview

Price
$13.50
Previous close
$13.56
Open
$13.46
Market cap
$1.14B
P/E ratio
49.9
52-week range
$6.46 - $15.89
1-year price target
$17.60
Sector
Healthcare
Industry
Medical - Devices
Exchange
NGS
MarketXLS Rank
66

About Bioventus Inc.

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprises of various intra-articular and hyaluronic acid injections, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise ultrasonic products offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; bone graft substitutes, a portfolio includes various products that facilitate optimal bone fusion. The company's product includes, nexus, an ultrasonic surgical system, an ultrasonic surgical platform; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite, a handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company's restorative therapies, which includes minimally invasive fracture treatments and rehabilitation products. Its products include Exogen, an ultrasound bone stimulation system; and Talisman pulse generator and receiver for peripheral nerve stimulation. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.

ABCD
1SymbolPriceChangeVol
2BVS$13.50-0.4%338.40K
3
4
5
6

Get Bioventus Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.